{"id":"W3111050887","doi":"10.1016/s0140-6736(20)32666-0","title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":364,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Saskatchewan","funders":"ViiV Healthcare","keywords":"Rilpivirine; Medicine; Human immunodeficiency virus (HIV); Internal medicine; Emtricitabine; Tenofovir; Open label; Clinical trial; Virology; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002504159,0.001874798,0.003273112,0.0004213153,0.0004010669,0.001559697,0.001174692,0.002328724,0.008486989],"category_scores_gemma":[0.001868035,0.0009019824,0.0021538,0.0004015186,0.001317664,0.001550715,0.0004592312,0.003065329,0.001510573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008700668,"about_ca_system_score_gemma":0.0009699556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001347808,"about_ca_topic_score_gemma":0.002691187,"domain_scores_codex":[0.99903,0.0005435276,0.00004250799,0.0001491958,0.00007813258,0.0001566329],"domain_scores_gemma":[0.9988915,0.0003337289,0.0002145653,0.0001256032,0.00006104476,0.0003735146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9792964,0.004805841,0.0006233266,0.0003702316,0.0007763922,0.00003998974,0.00006068938,0.0002493804,0.002529069,0.00009329469,0.0007624087,0.01039293],"study_design_scores_gemma":[0.9483007,0.04772672,0.002556678,0.00002367635,0.0003473314,0.00003728467,0.00002520128,0.0001987493,0.0001804146,0.0001298552,0.0004542937,0.00001916457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884034,0.004173685,0.0005339375,0.0005387317,0.0003214715,0.001741206,0.001931458,0.000147635,0.002208496],"genre_scores_gemma":[0.9849156,0.002305255,0.001938293,0.001378904,0.0004412973,0.002441258,0.001921461,0.00005181603,0.004606094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008486989,"threshold_uncertainty_score":0.02839178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03775309755968166,"score_gpt":0.3165012276065506,"score_spread":0.278748130046869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}